These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23083550)

  • 21. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can contrast-enhanced sonography distinguish benign from malignant breast masses?
    Sorelli PG; Cosgrove DO; Svensson WE; Zaman N; Satchithananda K; Barrett NK; Lim AK
    J Clin Ultrasound; 2010 May; 38(4):177-81. PubMed ID: 20146214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of ultrasound contrast media for the assessment of vascularization of breast tumors].
    Bang N; Nielsen MB
    Ugeskr Laeger; 2001 Aug; 163(33):4374-6. PubMed ID: 11521573
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast vascular tumors.
    López-Gutiérrez JC; Parrón M
    AJR Am J Roentgenol; 2008 Dec; 191(6):W322. PubMed ID: 19020227
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent.
    Frinking PJ; Tardy I; Théraulaz M; Arditi M; Powers J; Pochon S; Tranquart F
    Ultrasound Med Biol; 2012 Aug; 38(8):1460-9. PubMed ID: 22579540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies.
    Streeter JE; Gessner R; Miles I; Dayton PA
    Mol Imaging; 2010 Apr; 9(2):87-95. PubMed ID: 20236606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Let us utilize breast contrast-enhanced ultrasound more.
    Ito T
    J Med Ultrason (2001); 2018 Oct; 45(4):543-544. PubMed ID: 30269285
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography.
    Lyshchik A; Fleischer AC; Huamani J; Hallahan DE; Brissova M; Gore JC
    J Ultrasound Med; 2007 Nov; 26(11):1575-86. PubMed ID: 17957052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of staging of breast cancer and role of contrast ultrasound.
    Rizzatto G; Martegani A; Chersevani R; Macorig D; Vrtovec M; Aiani L; Tufarulo L
    Eur Radiol; 2001; 11 Suppl 3():E47-51. PubMed ID: 11793053
    [No Abstract]   [Full Text] [Related]  

  • 30. Contrast ultrasound in breast tumor characterization: present situation and future tracks.
    Madjar H
    Eur Radiol; 2001; 11 Suppl 3():E41-6. PubMed ID: 11793052
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbubble contrast-enhanced ultrasound for sentinel lymph node detection: ready for prime time?
    Yang WT; Goldberg BB
    AJR Am J Roentgenol; 2011 Feb; 196(2):249-50. PubMed ID: 21257872
    [No Abstract]   [Full Text] [Related]  

  • 32. Advanced ultrasound techniques for breast imaging.
    Piccoli CW; Forsberg F
    Semin Roentgenol; 2011 Jan; 46(1):60-7. PubMed ID: 21134529
    [No Abstract]   [Full Text] [Related]  

  • 33. Computer vision techniques for breast tumor ultrasound analysis.
    Alemán-Flores M; Alemán-Flores P; Alvarez-León L; Fuentes-Pavón R; Santana-Montesdeoca JM
    Breast J; 2008; 14(5):483-6. PubMed ID: 18821934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.
    Bachawal SV; Jensen KC; Wilson KE; Tian L; Lutz AM; Willmann JK
    Cancer Res; 2015 Jun; 75(12):2501-9. PubMed ID: 25899053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular morphologic information of three-dimensional power Doppler ultrasound is valuable in the classification of breast lesions.
    Yen PL; Wu HK; Tseng HS; Kuo SJ; Huang YL; Chen HT; Chen DR
    Clin Imaging; 2012; 36(4):267-71. PubMed ID: 22726963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the spatial extent of breast tumor intrinsic optical contrast using ultrasound and diffuse optical spectroscopy.
    Li A; Liu J; Tanamai W; Kwong R; Cerussi AE; Tromberg BJ
    J Biomed Opt; 2008; 13(3):030504. PubMed ID: 18601521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
    Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
    Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
    Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
    Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
    Unnikrishnan S; Klibanov AL
    AJR Am J Roentgenol; 2012 Aug; 199(2):292-9. PubMed ID: 22826389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to "Breast vascular tumors".
    Mesurolle B; Sygal V
    AJR Am J Roentgenol; 2009 Apr; 192(4):W192. PubMed ID: 19320072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.